Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing sales7@sinochem-nanjing.com 3389378665@qq.com
Follow us:

DL-Pipecolinic Acid

    • Product Name DL-Pipecolinic Acid
    • Alias Piperidine-2-carboxylic acid
    • Einecs 248-972-9
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry sales7@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    672120

    Product Name DL-Pipecolinic Acid
    Cas Number 535-75-1
    Molecular Formula C6H11NO2
    Molecular Weight 129.16 g/mol
    Appearance White to off-white crystalline powder
    Melting Point 256-258 °C (decomposition)
    Solubility Soluble in water
    Purity Typically ≥98%
    Synonyms Hexahydropyridine-2-carboxylic acid
    Ph 1 Solution Approx. 7.0-8.5
    Storage Temperature 2-8°C
    Chemical Structure Cyclic amino acid with a six-membered ring
    Odor Odorless
    Iupac Name Piperidine-2-carboxylic acid

    As an accredited DL-Pipecolinic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing DL-Pipecolinic Acid is packaged in a sealed 25g amber glass bottle with a secure screw cap, labeled for laboratory use.
    Shipping DL-Pipecolinic Acid is shipped in tightly sealed, labeled containers to prevent contamination and moisture absorption. Packaging complies with chemical safety regulations. Standard shipping is via ground or air, based on destination and urgency. All shipments include proper documentation and safety data sheets, ensuring secure handling and transport during transit.
    Storage DL-Pipecolinic Acid should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry place, ideally at room temperature (15-25°C) and away from incompatible substances such as strong oxidizers. For long-term storage, refrigeration (2-8°C) is recommended to maintain stability. Ensure proper labeling and follow relevant safety and handling guidelines.
    Application of DL-Pipecolinic Acid

    Applications of DL-Pipecolinic Acid in Industrial Manufacturing

    DL-Pipecolinic Acid, as produced by our advanced synthesis and purification platforms, plays a critical role in several high-value industrial manufacturing chains where traceability, regulatory compliance, and performance in end-use products are tightly controlled. Below, we outline actual application scenarios supported by quality benchmarks and industry-specific integration details.

    1. Pharmaceutical Intermediates for API Synthesis

    DL-Pipecolinic Acid serves as a pivotal intermediate in the synthesis of several piperidine-based active pharmaceutical ingredients, where precise isomeric purity is required to meet stringent regulatory and pharmacopoeial criteria. It enters the regulated API value chain as a building block for drugs targeting neurological and metabolic pathways, with every batch traceable to cGMP quality management. Bulk users integrate this raw material during early-stage alkylamination or cyclization steps to construct complex heterocyclic frameworks in finished medicines.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • European Pharmacopoeia Monograph 01/2017:0017 (where applicable as intermediate)
    • US FDA CFR Title 21 Part 211
    • EDQM CEP/DMF requirements for intermediates supply

    Typical usage ratio

    • Ranges from 3% to 15% (mole equivalent basis) of total batch mass in synthesis steps, adjusted according to target API yield, route design, and downstream step efficiency.

    Downstream process integration

    • Introduced at the intermediate formation stage via direct condensation, amidation, or ring closure; used as block reagent in controlled reaction vessels, followed by purification steps and continued chain extension or derivatization per API route.

    Final product types

    • Anticonvulsants (e.g., certain racetam derivatives)
    • Antiviral PI3K/Akt pathway modulators (experimental)
    • CNS-targeted APIs with substituted piperidine cores
    • Chiral drug intermediates for further resolution

    2. Chiral Resolving Agent and Asymmetric Synthesis

    Chiral technology units use this compound, particularly the DL form, in resolving enantiomeric mixtures and supporting asymmetric synthesis for fine chemicals. Demand primarily arises in sectors manufacturing optically active intermediates and custom pharmaceutical building blocks, where small deviations in starting material quality impact downstream enantiopurity and regulatory dossiers. The material is charged into reactors during the salt formation or crystallization phase, ensuring high selectivity in fractionation.

    Industry compliance standards

    • ICH Q11 Development and Manufacture of Drug Substances
    • ISO 9001:2015 Quality Management System
    • USP General Chapter <797> for compounding quality
    • GMP Annex 2 for investigational medicinal products

    Typical usage ratio

    • Used at 2-6% (wt/wt basis) per batch, with scaling based on the chiral substrate-to-resolving agent molar ratio; minor adjustment on solubility and crystallization kinetics.

    Downstream process integration

    • Input during the resolution or asymmetric conversion stage—solubilized and reacted with racemic substrates under controlled temperature, enabling separation or further derivatization before final purification of the desired enantiomer.

    Final product types

    • Chiral amine pharmaceuticals (e.g., enantiopure piperidine derivatives)
    • Custom optically active intermediates for late-stage API assembly
    • Chiral auxiliaries sold to other fine chemical processors

    3. Technical Additive in Biodegradable Polymer Synthesis

    DL-Pipecolinic Acid functions as a co-monomer or chain modifier in the formulation of specialty biodegradable polymers, such as polypeptides and polyamides, where its cyclic secondary amine structure imparts specific flexibility or degradation characteristics. Biopolymer manufacturers add it during the polymerization step under closely monitored thermal and pH conditions, with strict documentation to meet medical device or food contact regulations in target markets.

    Industry compliance standards

    • ISO 10993-5 Biological Evaluation of Medical Devices
    • REACH Regulation (EC) No 1907/2006 for monomer safety
    • FDA 21 CFR 177.1810 (if intended for food contact)
    • ISO 22000 for food polymer applications

    Typical usage ratio

    • Supplemented at 0.5-2.0% (mol/mol relative to main monomer), determined by target mechanical and biodegradability parameters and compatibility with the principal polymer matrix.

    Downstream process integration

    • Employed during melt or solution polymerization, mixed with the primary monomer feed, and allowed to react under inert atmosphere or vacuum, followed by extrusion or casting as per finished goods requirements.

    Final product types

    • Medical resorbable sutures
    • Biodegradable capsules and films
    • Eco-friendly packaging materials
    • Functionalized biomedical devices with tailored release properties

    4. Precursor for Agrochemical Active Ingredient Manufacture

    This specialty acid supplies a heterocyclic core for targeted synthesis routes in the agricultural chemical sector, especially for next-generation crop protection formulations where robust performance and residue reduction are mandated by regulators. Agrochemical plants batch it as a nucleophilic agent in ring construction reactions, directly impacting the chemical backbone that influences safety profiles and downstream product labeling.

    Industry compliance standards

    • FAO/WHO JMPR Pesticide Specifications
    • ISO 9001:2015 for agrochemical manufacturing
    • China Chemical Industry Standard GB 3796
    • OECD Guidelines for the Testing of Chemicals

    Typical usage ratio

    • Added at 3-7% (wt/wt of total reaction mass), with formulation refinement based on targeted chemical yield, active concentration, and impurity control plans.

    Downstream process integration

    • Charged during initial cyclization or functionalization, processed through multi-step synthesis including oxidation and coupling, followed by technical-grade isolation and preparation of formulated dispersible or soluble concentrates.

    Final product types

    • Novel herbicidal technical materials
    • Insecticide intermediates with piperidine-based moieties
    • Fungicide precursor compounds
    • Combination crop protection products (for co-formulated active delivery)
    Free Quote

    Competitive DL-Pipecolinic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: sales7@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    DL-Pipecolinic Acid: A Closer Look from the Production Floor

    What DL-Pipecolinic Acid Means to Us as a Manufacturer

    Every batch of DL-Pipecolinic Acid we produce represents the result of years of refining processes and quality vigilance. This isn’t just another compound on our production schedule. In the chemical industry, those of us fabricating cyclic amino acids quickly learn the significance of consistency from raw material sourcing to the final packed drum. DL-Pipecolinic Acid, a hexahydropyridinecarboxylic acid, puts our fermentation skills and purification equipment to the test every cycle.

    The Character of DL-Pipecolinic Acid: Composition and Appearance

    Our product presents itself typically as a white to off-white crystalline powder. There’s a reliable, clean odor to it that our team recognizes right away. Sometimes, the untrained eye might see two batches as identical, but subtle differences in sheen or flow tell a story. We rigorously monitor melting point, purity (usually above 99%), and moisture content during every run. Analytical checks—such as HPLC retention time and NMR spectral purity—aren’t just boxes to tick. They reveal real insights that inform us as manufacturers. If a shift in temperature or a slight change in agitation occurs, these show up in the product profile long before a customer ever files a complaint.

    Production Expertise: Fermentation vs. Synthetic Approaches

    DL-Pipecolinic Acid can be built either through fermentation or via chemical synthesis. We cut our teeth on chemical conversion of lysine, deploying robust hydrogenation setups to ensure ring closure and clean conversion. Some prefer biotransformation routes, making use of specific strains of Corynebacterium or engineered E. coli, which we acknowledge for their lower environmental burden but sometimes struggle with consistency at scale. Each method throws up different impurity profiles and variable yields. We’ve leaned into methods that limit solvent waste and let us harvest product in a recyclable mother liquor system. Every choice made on the floor must balance throughput, safety, and environmental impact—words you hear echoed in every planning meeting.

    Specifications: Meeting the Demands of Research and Industry

    Clients come to us with tight markups for purity and residual solvents. In research settings, we’ve encountered demands for DL-Pipecolinic Acid with no more than 0.2% water content and less than 0.1% single impurity by HPLC. Asking for detailed certificates of analysis and batch histories is standard practice in our daily routines. Large pharma orders often specify metal ion counts and organic residuals—details that require careful routine between our QC team and process operators. In our experience, laboratories request 5g or 25g vials, but industrial buyers call for kilogram or drum-scale orders, demanding sealed packaging under dry nitrogen and triple-bagged for shipment. There aren’t shortcuts. Any deviation from standard—whether particle size, bulk density, or even labeling requirements—has to be managed with proper internal documentation and validation.

    Switching from L-, D-, to DL- Forms: The Practical Differences

    L-Pipecolinic Acid and its D-isomer each matter depending on the downstream application. In many biological systems, enantioselectivity drives results. L-forms tie into metabolic pathways, especially when looking at animal feed or pharmaceutical intermediates. DL-Pipecolinic Acid, as a racemic mix, finds use in broader chemical synthesis and as a building block for chiral derivatizations. The market sometimes confuses the two, but for us as producers, these are very different processes. Separating enantiomers at scale is challenging and expensive, usually reserved for high-value medical use. Racemization checks and optical rotation measurements consume much of our analytical time when the market demands single-enantiomer purity. Our DL-version lets customers access both forms at once—flexibility that can reduce cost in early-phase research or in agricultural applications where stereospecificity is less critical.

    Usage: Where Our Product Moves Beyond the Plant

    DL-Pipecolinic Acid finds a surprising breadth of downstream uses. In our experience, pharmaceutical researchers reach for this compound as a starting scaffold—especially for developing CNS drugs, anticonvulsants, or enzyme inhibitors that target neurotransmitter pathways. Some polymer chemists build specialty nylon analogs and elastomers around its cyclic structure, leveraging the rigidity and hydrogen bonding it brings. We’ve shipped batches to academic labs investigating unusual ring systems or peptide mimics. Agrochemical companies design plant-growth regulators drawing on pipecolinic acid’s ring skeleton. In animal nutrition, the market steadily grows for functionalized amino acids, with some studies highlighting the value of pipecolinic acid analogs in livestock metabolic efficiency. Each sector expects different documentation, trace element reporting, and compliance with REACH or other international standards.

    Process Challenges and How We Navigate Them

    Running DL-Pipecolinic Acid isn’t always smooth. One recurring challenge is ring closure in the synthetic route, where incomplete conversion leads to lysine or other cyclic byproducts. Our veterans recognize the cues early—the smell, a frothy reaction surface, a lag in pH drop. During scale-up, maintaining the right temperature gradient keeps side reactions at bay. Sometimes, large-scale crystallization throws up fines that clog filters. Our operations team regularly works with R&D to adjust seed protocols and develop tailored solvent systems. In the biotechnological route, contamination threatens yield and purity. Batch logs become vital, as any aberration in cell growth usually points towards a trace contaminant in a single raw material shipment. We’ve learned to verify every lot of feedstock and monitor fermenter off-gassing in real time. Every misstep in the process gets archived, discussed in cross-shift meetings, and folded into training for the team.

    What Sets Our DL-Pipecolinic Acid Apart

    Manufacturing from the ground up gives us full visibility into every input and step. We never lose sight of how even slight temperature or pressure changes affect aromatic purity or the final polymorphic form. Sourcing feedstock lysine from vetted partners means we see fewer batch failures. Using closed-system reactors with in-line monitoring, we can fine-tune the process to drive up yields and suppress undesired isomers. Feedback from our bulk customers prompted us to increase sieve retention and cut caking risk for large containers. Confidence in our quality control builds customer loyalty. We routinely share in-depth batch data and trend analyses—not just for regulatory audits but for clients looking to optimize their own synthesis routes. From our perspective, these kinds of partnerships improve both product quality and end-use performance.

    Regulatory and Safety Considerations

    Any chemical manufacturer knows that running an operation safely takes more than written procedures. Our handling of DL-Pipecolinic Acid includes standard precautions you’d recognize in any well-run facility—dust collection, localized extraction, clear PPE protocols, and locked chemical storage. One operator catching an off-spec material during repacking can stop a problem from ever moving downstream. Regular training on spill response, first aid, and proper labeling ensures everyone stays up-to-date. When our customers want to know about shipping classifications or require special handling documents, we deliver clear, accurate reports every time. Traceability lets us meet global requirements—whether REACH in Europe, TSCA in the US, or comparable safeguards in Asia. Our culture rewards a “see something, say something” mindset, both for compliance and for genuine workplace safety.

    Comparisons: How DL-Pipecolinic Acid Stands Out Among Related Amines and Acids

    Comparing DL-Pipecolinic Acid with similar heterocyclic amino acids, we see distinct differences in chemical reactivity and application profiles. Take proline as an example. Both compounds share a cyclic backbone, but proline’s five-membered ring brings increased backbone flexibility—useful in peptide chemistry but less so in polymer building blocks, where pipecolinic acid’s six-membered ring brings added rigidity. Substituted pyrrolidines or piperidines pop up as synthetic intermediates, but our customers that require a secondary amino group with a carboxylate attached at the 2-position keep coming back for DL-Pipecolinic Acid for specific stereochemical and solubility attributes.

    Other manufacturers sometimes offer semi-refined pipecolinic acid derivatives, yet chasing higher purity brings diminishing returns without robust process controls. Our own investments in in-line spectrometry and reactor feedback circuits let us deliver tighter impurity windows. As makers, we keep a keen eye on competitors’ batch consistency. Customers report better color stability or less residual solvent in our material, which often leads to fewer rejects in downstream formulation.

    Transportation, Storage, and Practical Handling

    Bulk shipment of DL-Pipecolinic Acid comes with its own realities. Moisture uptake risks product breakdown, so we pack in multiple barrier layers, layering desiccants and using nitrogen-purged drums for higher volumes. As a team, we’ve developed clear batch release criteria and shipping controls—tracking every container from our dock to the recipient’s door, monitoring for vibration or temperature spikes that might affect product quality.

    We also accommodate customers requesting custom-sized packs or single-use liners for GMP production. Our logistics team schedules shipments to avoid long layovers in adverse weather, understanding how temperature swings can shift caking behavior. Storage guidelines come directly from our experience: keep the material below 25°C, avoid direct sunlight, and check the integrity of seals before opening. We share these best practices with every client—not just as a checkbox for compliance, but because we’ve seen how small oversights can waste months of careful process work.

    Quality Control and Traceability: Lessons Learned

    Many of our hard-earned lessons originated in customer-driven improvement cycles. Early on, we saw occasional color or odor drift that laboratory-grade purity didn’t fully predict. We dug into batch records, traced issues to a lot of unfiltered solvent, and retooled our filtration setup. Our site runs a “no batch leaves without secondary review” policy. Full traceability from raw material lot to final shipment not only meets international demands for transparency, but also lets us improve every run.

    Auditors and customers alike appreciate transparency—not just a few high-level words on a certificate, but raw data that traces every significant action, deviation, and recovery step. We keep extensive analytical logs, from Karl Fischer titrations to residual solvent profiles. When customers require tailored documentation, we back our claims with methodologies and instrument calibration logs, so there’s never a question about data integrity. Each complaint or return is logged, dissected, remediated, and flagged for continuous improvement. Even now, we remain vigilant; new applications or regulations challenge what we thought we knew.

    Future Directions and Adaptations on the Shop Floor

    Looking ahead, we see demand shifting towards greener production routes. Our R&D team experiments with lower-energy bioconversions and safer solvents. Customers express interest in lifecycle impact, so we share data on water use, energy consumption, and waste-to-product ratios. We respond by piloting waste minimization and solvent recovery schemes in parallel with each batch. Pushing toward continuous flow systems promises to bring both safety and efficiency gains, even if the initial outlay feels steep.

    We compete on quality, delivery, and the certainty that every drum meets or surpasses agreed specifications. As a manufacturer, we never lose sight of the scales, valves, and lab benches that deliver consistency batch after batch. Our people, from synthesis operators to logistics planners, drive progress not just with technology, but by distilling field experience into smarter routines. For us, DL-Pipecolinic Acid stands as a testament to the value of hands-on expertise and relentless attention to detail.